Similar to the actions of AM1710, SR141716 (CB1R antagonist) also blocked the diabetes-induced increase of vascular permeability, suggesting that the blockade of CB1R is efficacious in maintaining the integrity of BRB. Here, CNR1 is linked to diabetes mellitus.